Quinolones Market Report 2026

Quinolones Market Overview

• Quinolones market size has reached to $51.89 billion in 2025 • Expected to grow to $66.44 billion in 2030 at a compound annual growth rate (CAGR) of 5.1% • Growth Driver: Rising Threat Of Antimicrobial Resistance Is A Catalyst For Quinolones Market Growth • Market Trend: Cutting-Edge Fluoroquinolone Antibiotic Eye Drop For Effective Ocular Infection Prevention • North America was the largest region in 2025.

What Is Covered Under Quinolones Market?

Quinolones refer to bactericidal antibiotics that directly kill bacteria cells of both gram-positive and gram-negative types. Quinolones are used to treat various infectious diseases caused by bacteria. The main types of quinolones norfloxacin, ofloxacin, ciprofloxacin, gemifloxacin, and others. Norfloxacin refers to fluoroquinolone used to treat various bacterial infections. Norfloxacin is used to treat conjunctivitis and urinary tract infections. The pathogen types include gram-positive pathogens, and gram-negative pathogens. The various applications include hospital pharmacies, retail pharmacies, and online pharmacies.

What Is The Quinolones Market Growth Forecast?

The quinolones market size is expected to see strong growth in the next few years. It will grow to $66.44 billion in 2030 at a compound annual growth rate (CAGR) of 5.1%. The growth in the forecast period can be attributed to advancements in precision medicine, development of novel quinolone formulations, expansion of online pharmacy channels, increasing awareness about antimicrobial stewardship, rising adoption of digital health monitoring tools. Major trends in the forecast period include rising antibiotic resistance management, expansion of generic drug availability, personalized treatment approaches, growth in outpatient and home healthcare services, increased investment in r&d for novel quinolones.

Global Quinolones Market Segmentation

1) By Type: Norfloxacin, Ofloxacin, Ciprofloxacin, Gemifloxacin, Other Types 2) By Pathogen Type: Gram-Positive Pathogen, Gram-Negative Pathogen 3) By Application: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

What Is The Driver Of The Quinolones Market?

The increasing danger of antimicrobial resistance is expected to propel the growth of the quinolones market going forward. Antimicrobial resistance (AMR) refers to the ability of microorganisms, such as bacteria, viruses, parasites, and fungi, to resist the effects of antimicrobial drugs. Quinolones have a broad spectrum of activity, making them effective against a variety of bacteria. Prescribed for specific types of infections, they have the ability to penetrate various tissues and become a preferred choice in case of limited options. For instance, in October 2025, according to the World Health Organization, a US-based intergovernmental organization, A comprehensive global analysis examined antibiotic resistance prevalence and trends using data from more than 23 million confirmed cases of bloodstream, urinary tract, and gastrointestinal infections and urogenital gonorrhea. The findings are based on reports submitted by 104 countries in 2023. Therefore, the increasing danger of antimicrobial resistance is driving the growth of the quinolones industry.

Key Players In The Global Quinolones Market

Major companies operating in the quinolones market are Bayer AG, Novartis AG, Sanofi SA, Merck & Co. Inc., LG Life Sciences, Pfizer Inc., Viatris Inc., Lupin Limited, Hikma Pharmaceuticals plc, Zydus Group, KYORIN Holdings Inc., Teva Pharmaceutical Industries Ltd., GSK plc, Zee Laboratories, Cipla Ltd., Geo Pharma Pvt. Ltd., Finecure Pharmaceuticals, AstraZeneca plc, Sun Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd., Cadila Healthcare Ltd., Glenmark Pharmaceuticals Ltd., Alkem Laboratories Ltd., Torrent Pharmaceuticals Ltd., Macleods Pharmaceuticals Ltd., Alembic Pharmaceuticals Ltd., Hetero Drugs Ltd., Wockhardt Ltd.

Global Quinolones Market Trends and Insights

Major companies operating in the quinolones market are focusing on innovative products such as fluoroquinolone antibiotic eye drop to drive revenues in their market. Fluoroquinolone antibiotic eye drops are a class of antibiotics that are used to treat bacterial infections of the eye. For instance, in July 2023, Harrow Health Inc. a US-based pharmaceutical company launched Vigamox. The solution is isotonic, with an osmolality of about 290 mOsm/kg, and contains 5.45 mg moxifloxacin hydrochloride, which is equal to 5 mg moxifloxacin base. The medication comes in a 3-milliliter bottle and is delivered as a sterile ophthalmic solution in a dispensing system made up of a tan polypropylene closure, a dispensing plug, and a natural low-density polyethylene bottle. Vigamox is recommended for the prevention of eye infections both before and after surgery.

What Are Latest Mergers And Acquisitions In The Quinolones Market?

In June 2023, Bausch + Lomb Incorporated a US-based eye health company that specializes in the development, manufacturing, and marketing of a wide range of eye care products acquired Novartis International AG for an undisclosed amount. With this acquisition, Bausch & Lomb plans to restructure its pharmaceutical division by giving it the necessary scale and elevating the organization to the forefront of ocular surface disorders. Novartis International AG is a Switzerland-based pharmaceutical company.

Regional Insights

North America was the largest region in the quinolones market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Quinolones Market?

The quinolones market consists of sales of bedaquiline. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Quinolones Market Report 2026?

The quinolones market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the quinolones industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.